MetLife (MET) is a Top Dividend Stock Right Now: Should You Buy?

31.03.25 17:45 Uhr

Werte in diesem Artikel
Aktien

74,34 EUR -0,83 EUR -1,10%

15,90 EUR 0,20 EUR 1,27%

Indizes

PKT PKT

16.801,5 PKT -51,1 PKT -0,30%

2.720,9 PKT 11,1 PKT 0,41%

5.633,1 PKT 21,2 PKT 0,38%

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.Cash flow can come from bond interest, interest from other types of investments, and of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.MetLife in FocusBased in New York, MetLife (MET) is in the Finance sector, and so far this year, shares have seen a price change of -3.24%. Currently paying a dividend of $0.55 per share, the company has a dividend yield of 2.75%. In comparison, the Insurance - Multi line industry's yield is 1.56%, while the S&P 500's yield is 1.59%.In terms of dividend growth, the company's current annualized dividend of $2.18 is up 1.2% from last year. Over the last 5 years, MetLife has increased its dividend 5 times on a year-over-year basis for an average annual increase of 4.31%. Any future dividend growth will depend on both earnings growth and the company's payout ratio; a payout ratio is the proportion of a firm's annual earnings per share that it pays out as a dividend. MetLife's current payout ratio is 27%. This means it paid out 27% of its trailing 12-month EPS as dividend.Earnings growth looks solid for MET for this fiscal year. The Zacks Consensus Estimate for 2025 is $9.55 per share, representing a year-over-year earnings growth rate of 17.76%.Bottom LineInvestors like dividends for many reasons; they greatly improve stock investing profits, decrease overall portfolio risk, and carry tax advantages, among others. But, not every company offers a quarterly payout.For instance, it's a rare occurrence when a tech start-up or big growth business offers their shareholders a dividend. It's more common to see larger companies with more established profits give out dividends. Income investors have to be mindful of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, MET is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of 3 (Hold).Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report MetLife, Inc. (MET): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: MetLife und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf MetLife

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf MetLife

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu MetLife Inc.

Wer­bung

Analysen zu MetLife Inc.

DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
DatumRatingAnalyst
03.11.2017MetLife OutperformRBC Capital Markets
25.05.2017MetLife OutperformFBR & Co.
05.05.2016MetLife OutperformRBC Capital Markets
31.07.2015MetLife BuyDeutsche Bank AG
22.06.2015MetLife OutperformRBC Capital Markets
DatumRatingAnalyst
02.01.2018MetLife HoldDeutsche Bank AG
09.12.2016MetLife HoldStandpoint Research
28.11.2016MetLife Mkt PerformFBR & Co.
13.07.2016MetLife HoldDeutsche Bank AG
15.03.2016MetLife NeutralUBS AG
DatumRatingAnalyst
04.12.2006Update MetLife Inc.: UnderperformFriedman, Billings Ramsey & Co
14.09.2005MetLife DowngradeDeutsche Securities
14.09.2005Update MetLife Inc.: SellDeutsche Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für MetLife Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen